Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 1092507, 8 pages
https://doi.org/10.1155/2017/1092507
Clinical Study

Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma

1Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan 450008, China
2School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
3Department of Research and Foreign Affairs, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan 450008, China
4Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA

Correspondence should be addressed to Wei Li; moc.361@14869930951 and Quanli Gao; moc.nuyila@1ilnauqoag

Received 26 March 2017; Accepted 28 June 2017; Published 20 August 2017

Academic Editor: Chuanlai Shen

Copyright © 2017 Wei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wei Li, Linping Xu, Yaomei Wang, Lingdi Zhao, Daniel B. Kellner, and Quanli Gao, “Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma,” Journal of Immunology Research, vol. 2017, Article ID 1092507, 8 pages, 2017. https://doi.org/10.1155/2017/1092507.